These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 9368297

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.
    Preston DL, Kusumi S, Tomonaga M, Izumi S, Ron E, Kuramoto A, Kamada N, Dohy H, Matsuo T, Matsui T [corrected to Matsuo T].
    Radiat Res; 1994 Feb; 137(2 Suppl):S68-97. PubMed ID: 8127953
    [Abstract] [Full Text] [Related]

  • 5. Dose-response relationship of neutrons and gamma rays to leukemia incidence among atomic bomb survivors in Hiroshima and Nagasaki by type of leukemia, 1950--1971.
    Ishimaru T, Otake M, Ischimaru M.
    Radiat Res; 1979 Feb; 77(2):377-94. PubMed ID: 286375
    [No Abstract] [Full Text] [Related]

  • 6. [Health effects of atomic bomb radiation].
    Shigematsu I.
    Rinsho Byori; 1994 Apr; 42(4):313-9. PubMed ID: 8176838
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The observed relationship between the occurrence of acute radiation effects and leukemia mortality among A-bomb survivors.
    Neriishi K, Stram DO, Vaeth M, Mizuno S, Akiba S.
    Radiat Res; 1991 Feb; 125(2):206-13. PubMed ID: 1996379
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Absence of evidence for differences in the dose-response for cancer and non-cancer endpoints by acute injury status in the Japanese atomic-bomb survivors.
    Little MP.
    Int J Radiat Biol; 2002 Nov; 78(11):1001-10. PubMed ID: 12456287
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Neutrons at Hiroshima: how their disappearance affected risk estimates.
    Ellett WH.
    Radiat Res; 1991 Oct; 128(1 Suppl):S147-52. PubMed ID: 1924742
    [Abstract] [Full Text] [Related]

  • 18. Cancer risks and biomarker studies in the atomic bomb survivors.
    Preston D.
    Stem Cells; 1995 May; 13 Suppl 1():40-8. PubMed ID: 7488967
    [Abstract] [Full Text] [Related]

  • 19. Malignancies in atomic bomb survivors in Hiroshima and Nagasaki.
    Shimaoka K, Akiba S.
    J Nucl Med Allied Sci; 1990 May; 34(4):254-9. PubMed ID: 2090789
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.